Last reviewed · How we verify
NCT07535996
IBM Dietary Surveillance Study
trial testing Whole-Body Dual-Energy X-ray Absorptiometry in Inclusion Body Myositis in 47 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | Manchester Metropolitan University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 47 |
| Start date | 30 April 2026 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Whole-Body Dual-Energy X-ray Absorptiometry
- Anthropometry
- Capillary Blood Sampling — full drug profile →
- Indirect Calorimetry
- Magnetic Resonance Imaging
- Dynamometry
- Behavioural Monitoring
Conditions studied
- Inclusion Body Myositis — all drugs for Inclusion Body Myositis →
Sponsor
Manchester Metropolitan University
Who can join
40 and older, any sex, with Inclusion Body Myositis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to understand how diet may influence the disease characteristics of inclusion body myositis (IBM). Research findings will help determine whether dietary factors could play a role in managing IBM. The study aims to answer the question: Does diet affect the muscle health and functional ability of people living with IBM? Researchers will compare adults with IBM to healthy volunteers aged 40 years and older. This comparison will help to identify which findings are related to normal ageing and which are specific to IBM. Participants will: Attend an initial screening visit at the Manchester Metropolitan University Institute of Sport to confirm eligibility and explain study procedures. Complete four weeks of home-based monitoring, including dietary records, physical activity monitoring, and questionnaires about lifestyle and symptoms. Attend a second university visit for assessments of body composition, metabolism, and muscle function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07535996
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Inclusion Body Myositis
Currently open trials in the same condition.
- NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
- NCT05046821 — Sporadic Inclusion Body Myositis Natural History Study · active not recruiting
- NCT00017914 — Adult and Juvenile Myositis · recruiting
Other Manchester Metropolitan University trials
Trials by the same sponsor.
- NCT06827691 — Heat Therapy and Peripheral Artery Disease · NA · not yet recruiting
- NCT06624774 — Prehabilitation's Effect on Skeletal Muscle Mass in Cardiac Patients · NA · active not recruiting
- NCT05784272 — Determinants of Progression From Phase III to IV Cardiac Rehabilitation · unknown
- NCT06063733 — Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD · NA · unknown
- NCT05588479 — Pomegranate Extract and Inflammageing · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07535996 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Manchester Metropolitan University
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07535996.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing